z-logo
open-access-imgOpen Access
In vitroactivities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistantPseudomonas aeruginosaandAcinetobacter baumannii, andStenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
Author(s) -
Shun-Chung Hsueh,
YuarnJang Lee,
YuTsung Huang,
ChunHsing Liao,
Masakatsu Tsuji,
PoRen Hsueh
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky425
Subject(s) - imipenem , acinetobacter baumannii , stenotrophomonas maltophilia , colistin , microbiology and biotechnology , pseudomonas aeruginosa , ceftazidime/avibactam , broth microdilution , biology , ceftazidime , acinetobacter , antimicrobial , minimum inhibitory concentration , antibiotics , antibiotic resistance , bacteria , genetics
We investigated the in vitro activities of cefiderocol, ceftazidime/avibactam, ceftolozane/tazobactam and other related drugs against imipenem-resistant Pseudomonas aeruginosa, imipenem-resistant Acinetobacter baumannii and Stenotrophomonas maltophilia isolates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom